The hemp cannabinoid marketplace has spent the last few years evolving at a fevered pace. However, for the first time in several years, we’re beginning to see a more mature marketplace, market participants, and most importantly, consumers. The market is now engaging in a renewed focus on scaling towards stricter best practices and regulatory frameworks. Please join us as we discuss not only where the marketplace is, but more so,… More
Monthly Archives: August 2021
The New Jersey Cannabis Regulatory Commission (“CRC”) – ahead of schedule – just released its adult-use regulations, thereby taking the first step towards opening up its adult-use marketplace. While there is a tremendous amount of information to digest in the 160 pages of regulations, and the myriad implications and questions flowing from it, our cannabis team wanted to provide a brief overview of the relevant implications.
In short,… More
More than two years have passed since hemp-derived cannabidiol (CBD) was legalized in the United States under the Agriculture Improvement Act of 2018 (also known as the “Farm Bill”).
The Food and Drug Administration (FDA) has been exploring potential regulatory pathways for CBD but it has yet to engage in rulemaking or issue guidance that would provide a clear framework under which FDA could maintain oversight over CBD to ensure that its use in a range of products is safe.… More